Jaime Contreras Form 4 ABBOTT LABORATORIES / Jaime Contreras ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Contreras Jaime

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	01/30/2019		M		46,017	A	$44.4	100,985	D
Common shares without par value	01/30/2019		M		84,169	A	$38.4	185,154	D
Common shares without par value	01/30/2019		M		83,951	A	$47	269,105	D
Common shares without par value	01/30/2019		S		177,457	D	$70	91,648	D
Common shares without par value	01/31/2019		M		62,600	A	$47	154,248	D
Common shares without par value	01/31/2019		M		77,550	A	$38.4	231,798	D
Common shares without par value	01/31/2019		F		108,090	D	$71.68	111,301(1)	D
Common shares without par value								22(2)	I	Profit Sharing Trust
Common shares without par value								84,579(3)	I	Jaime Contreras Marvan 2006 Living Trust
Common shares without par value								2,595(4)	I	By Spouse
Common shares without par value								12,081(5)	I	Living Trust (by spouse)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)(6)	$44.4	01/30/2019		M			46,017	02/17/2018	02/16/2027	Common Shares	46,017	$0	92,032	D
Option (right to buy)(6)	$38.4	01/30/2019		M			84,169	02/19/2017	02/18/2026	Common Shares	84,169	$0	158,410	D
Option (right to buy)(6)	$47	01/30/2019		M			83,951	02/20/2016	02/19/2025	Common Shares	83,951	$0	62,600	D
Option (right to buy)(6)	$47	01/31/2019		M			62,600	02/20/2018	02/19/2025	Common Shares	62,600	$0	0	D
Option (right to buy)(6)	$38.4	01/31/2019		M			77,550	02/19/2018	02/18/2026	Common Shares	77,550	$0	80,860	D

Explanation of Responses:

1. Excludes 12,407 shares previously directly owned which were transferred to the Jaime Contreras Marvan 2006 Living Trust on September 21, 2018.

2. Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2019.

3. Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

4. The reporting person disclaims beneficial ownership of all securities held by his spouse.

5. Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.

6. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

	Jessica H. Paik, by power of attorney for Jaime Contreras	02/01/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.